| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
2.279 ADVERSE EVENTS TO ANTIPARKINSONIAN MEDICATIONS IN PARKINSONIAN AND NON-PARKINSONIAN PATIENTS
|
Perez-Lloret, S.
|
|
2012
|
18 |
Supplement 2 |
p. S135-
1 p.
|
artikel
|
| 2 |
2.3.3 A GENOME-WIDE ANALYSIS IN THE EUROPEAN HD POPULATION
|
Landwehrmeyer, G.B.
|
|
2012
|
18 |
Supplement 2 |
p. S83-
1 p.
|
artikel
|
| 3 |
Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease
|
Yonova-Doing, Ekaterina
|
|
2012
|
18 |
Supplement 2 |
p. 567-571
5 p.
|
artikel
|
| 4 |
1.029 ANALYSIS OF NON-MOTOR SYMPTOMS OF PARKINSON'S DISEASE
|
Meng, L.
|
|
2012
|
18 |
Supplement 2 |
p. S17-
1 p.
|
artikel
|
| 5 |
1.043 ANALYSIS OF SAWLOWING SOUNDS THROUGH SONAR DOPPLER IN PATIENTS WITH PARKINSONS DISEASE
|
Santos, R.S.
|
|
2012
|
18 |
Supplement 2 |
p. S20-
1 p.
|
artikel
|
| 6 |
3.123 A NOVEL BAC α-SYNUCLEIN-GFP TRANSGENIC MOUSE MODEL FOR IMAGING OF α-SYNUCLEIN AGGREGATION
|
Hansen, C.
|
|
2012
|
18 |
Supplement 2 |
p. S194-S195
2 p.
|
artikel
|
| 7 |
Apolipoprotein E gene (APOE) genotype in Wilson’s disease: Impact on clinical presentation
|
Litwin, T.
|
|
2012
|
18 |
Supplement 2 |
p. 367-369
3 p.
|
artikel
|
| 8 |
Apomorphine injections: Predictors of initial common adverse events and long term tolerability
|
Ondo, William G.
|
|
2012
|
18 |
Supplement 2 |
p. 619-622
4 p.
|
artikel
|
| 9 |
Assessment of appropriate medication administration for hospitalized patients with Parkinson’s disease
|
Hou, Jyhgong Gabriel
|
|
2012
|
18 |
Supplement 2 |
p. 377-381
5 p.
|
artikel
|
| 10 |
3.017 ASSOCIATION OF MUTATIONS IN THE GLUCOCEREBROSIDASE GENE WITH PARKINSON DISEASE IN A KOREAN POPULATION
|
Kim, Y.J.
|
|
2012
|
18 |
Supplement 2 |
p. S173-
1 p.
|
artikel
|
| 11 |
Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease
|
Prakash, Bhaskaran David
|
|
2012
|
18 |
Supplement 2 |
p. 1029-1033
5 p.
|
artikel
|
| 12 |
3.062 ATAXIN-2 INTERMEDIATE POLYGLUTAMINE EXPANSIONS CONTRIBUTE TO RISK OF ALS AND OF EARLY ONSET HEREDITARY PD
|
Gispert, S.
|
|
2012
|
18 |
Supplement 2 |
p. S184-
1 p.
|
artikel
|
| 13 |
3.072 AUTISM SPECTRUM DISORDER ASSOCIATED WITH LOW BRAIN SEROTONIN AND MUTATIONS IN THE SEROTONIN TRANSPORTER SLC29A 4 AND IN SEROTONIN RELATED GENES
|
Adamsen, D.
|
|
2012
|
18 |
Supplement 2 |
p. S187-
1 p.
|
artikel
|
| 14 |
Autosomal dominant Parkinsonism: its etiologies and differential diagnoses
|
Hattori, Nobutaka
|
|
2012
|
18 |
Supplement 2 |
p. S1-S3
3 p.
|
artikel
|
| 15 |
Autosomal recessive parkinsonism
|
Bonifati, Vincenzo
|
|
2012
|
18 |
Supplement 2 |
p. S4-S6
3 p.
|
artikel
|
| 16 |
3.228 BEHAVIORAL EFFECTS OF A NOVEL DIPEPTIDE MIMETIC OF THE NERVE GROWTH FACTOR IN RODENT MODELS OF PARKINSON'S DISEASE
|
Povarnina, P.
|
|
2012
|
18 |
Supplement 2 |
p. S210-
1 p.
|
artikel
|
| 17 |
Body mass index in Parkinson’s disease: A meta-analysis
|
van der Marck, Marjolein A.
|
|
2012
|
18 |
Supplement 2 |
p. 263-267
5 p.
|
artikel
|
| 18 |
Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease
|
Liu, Jia
|
|
2012
|
18 |
Supplement 2 |
p. 140-143
4 p.
|
artikel
|
| 19 |
3.217 CDNF PROTECTS THE NIGROSTRIATAL DOPAMINE SYSTEM AND PROMOTES RECOVERY AFTER MPTP TREATMENT IN MICE
|
Airavaara, M.
|
|
2012
|
18 |
Supplement 2 |
p. S207-S208
2 p.
|
artikel
|
| 20 |
2.036 CEREBRAL GLUCOSE METABOLISM IN PROGRESSIVE SUPRANUCLEAR PALSY
|
Ma, A.
|
|
2012
|
18 |
Supplement 2 |
p. S100-
1 p.
|
artikel
|
| 21 |
1.17.1 CHOREA AND RELATED DISORDER
|
Zhang, B.
|
|
2012
|
18 |
Supplement 2 |
p. S8-
1 p.
|
artikel
|
| 22 |
Classifying myoclonus: A riddle, wrapped in a mystery, inside an enigma
|
Carr, Jonathan
|
|
2012
|
18 |
Supplement 2 |
p. S174-S176
3 p.
|
artikel
|
| 23 |
Clinical correlates of anterior and lateral flexion of the thoracolumbar spine and dropped head in patients with Parkinson’s disease
|
Kashihara, Kenichi
|
|
2012
|
18 |
Supplement 2 |
p. 290-293
4 p.
|
artikel
|
| 24 |
1.046 CLINICAL CORRELATES OF APATHY IN EARLY PARKINSON DISEASE: THE ANIMO STUDY
|
Cubo, E.
|
|
2012
|
18 |
Supplement 2 |
p. S21-
1 p.
|
artikel
|
| 25 |
Clinical management of pain and fatigue in Parkinson's disease
|
Del Sorbo, Francesca
|
|
2012
|
18 |
Supplement 2 |
p. S233-S236
4 p.
|
artikel
|
| 26 |
1.012 CLINICAL SCENARIO OF PATIENTS WITH PARKINSONISM: A MONGOLIAN STUDY
|
Sosorburam, T.
|
|
2012
|
18 |
Supplement 2 |
p. S13-
1 p.
|
artikel
|
| 27 |
1.205 COEXISTENCE OF ALS/ET/PD AND ALS/ET/MSA IN TWO DIFFERENT FAMILIES
|
He, X.
|
|
2012
|
18 |
Supplement 2 |
p. S48-
1 p.
|
artikel
|
| 28 |
Cognitive dysfunction in Tunisian LRRK2 associated Parkinson’s disease
|
Ben Sassi, Samia
|
|
2012
|
18 |
Supplement 2 |
p. 243-246
4 p.
|
artikel
|
| 29 |
2.113 CONTRAST SENSITIVITY VISUAL ACUITY IS DEFICIENT IN PARKINSON'S DISEASE AND DEGRADES MOTOR PERFORMANCE
|
Swigler, C.
|
|
2012
|
18 |
Supplement 2 |
p. S104-S105
2 p.
|
artikel
|
| 30 |
Cortical control of voluntary saccades in Parkinson's disease and pre-emptive perception
|
Javaid, M.A.
|
|
2012
|
18 |
Supplement 2 |
p. S100-S103
4 p.
|
artikel
|
| 31 |
1.115 DECREASED MOTOR CORTICAL INHIBITION AND INCREASED FACILITATION IN PARKINSON'S DISEASE
|
Ni, Z.
|
|
2012
|
18 |
Supplement 2 |
p. S39-
1 p.
|
artikel
|
| 32 |
3.059 DE NOVO MUTATED ATAXIN-2 INTERMEDIATE-LENGTH POLYGLUTAMINE ASSOCIATED WITH FAMILIAR ALS AND PARKINSONISM/ESSENTIAL TREMOR
|
Laffita, J.
|
|
2012
|
18 |
Supplement 2 |
p. S183-
1 p.
|
artikel
|
| 33 |
3.343 DEREGULATED MIRNA-184 INDUCES CELL CYCLE RE-ENTRY AND APOPTOSIS OF POSTMITOTIC DOPAMINERGIC NEURONS VIA REGULATION OF E2F IN PARKINSON DISEASE
|
Zhang, Z.
|
|
2012
|
18 |
Supplement 2 |
p. S229-S230
2 p.
|
artikel
|
| 34 |
3.260 D-β-HYDROXYBUTYRATE IS NEUROPROTECTIVE IN MOUSE MODELS OF HUNTINGTON'S DISEASE
|
Lim, S.
|
|
2012
|
18 |
Supplement 2 |
p. S218-
1 p.
|
artikel
|
| 35 |
Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: A meta-analysis of published studies
|
Papathanasiou, Nikolaos D.
|
|
2012
|
18 |
Supplement 2 |
p. 225-229
5 p.
|
artikel
|
| 36 |
2.005 DIFFERENT SIGNALS OF MAGNETIC RESONANCE IMAGING AND ULTRASOUND FROM PARKINSONIAN SUBSTANTIA NIGRA AND CONTROL – IS IRON THE CAUSE?
|
Galazka-Friedman, J.
|
|
2012
|
18 |
Supplement 2 |
p. S92-
1 p.
|
artikel
|
| 37 |
Direct costs and survival of medicare beneficiaries with early and advanced parkinson’s disease
|
Kaltenboeck, A.
|
|
2012
|
18 |
Supplement 2 |
p. 321-326
6 p.
|
artikel
|
| 38 |
Dyskinesias in patients with Parkinson's disease: Effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation
|
Yahalom, Gilad
|
|
2012
|
18 |
Supplement 2 |
p. 1039-1041
3 p.
|
artikel
|
| 39 |
2.341 EARLY, POSTOPERATIVE MICROLESION EFFECT AS A PREDICTOR OF SUBTHALAMIC DEEP BRAIN STIMULATION EFFECTIVENESS FOR PARKINSON'S DISEASE
|
Tykocki, T.
|
|
2012
|
18 |
Supplement 2 |
p. S151-
1 p.
|
artikel
|
| 40 |
Editorial Board
|
|
|
2012
|
18 |
Supplement 2 |
p. i-
1 p.
|
artikel
|
| 41 |
1.325 EFFECT OF LEVETIRACETAM MONOTHERAPY ON EPILEPTIC TODDLERS WITH CEREBRAL PALSY: A OPEN, PROSPECTIVE, SHORT-TERM AND CONTROLLED CLINICAL TRIAL
|
Jia, F.
|
|
2012
|
18 |
Supplement 2 |
p. S78-
1 p.
|
artikel
|
| 42 |
2.022 EFFECT OF PRAMIPEXOLE ON REGIONAL CEREBRAL BLOOD FLOW IN PARKINSON'S DISEASE
|
Hirano, S.
|
|
2012
|
18 |
Supplement 2 |
p. S96-
1 p.
|
artikel
|
| 43 |
2.237 EFFECT OF TETRAHYDROBIOPTERIN AND PHARMACOLOGICAL CHAPERONES ON TYROSINE HYDROXYLASE; CORRECTION OF NEUROTRANSMITTER DEFICIENCIES
|
Ying, M.
|
|
2012
|
18 |
Supplement 2 |
p. S124-
1 p.
|
artikel
|
| 44 |
2.220 EFFECTS OF ENGRAFTED HAIR FOLLICLE STEM CELLS IN ALZHEIMER'S DISEASE RATS
|
Nobakht, M.
|
|
2012
|
18 |
Supplement 2 |
p. S119-
1 p.
|
artikel
|
| 45 |
2.293 EFFECTS OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON PARKINSONISM OF MULTIPLE SYSTEM ATROPHY: CLINICAL, ELECTROPHYSIOLOGICAL AND FUNCTIONAL MRI STUDY
|
Wang, H.
|
|
2012
|
18 |
Supplement 2 |
p. S139-
1 p.
|
artikel
|
| 46 |
2.327 EFFICACY OF CHRONIC BILATERAL STN-DBS ON ALTERED EYE-TO-FOOT CO-ORDINATION IN STANDING ADVANCED PARKINSONIAN PATIENTS DURING LARGE GAZE AND WHOLE-BODY REORIENTATIONS
|
Naushahi, M.J.
|
|
2012
|
18 |
Supplement 2 |
p. S148-
1 p.
|
artikel
|
| 47 |
1.319 ELECTRONYSTAGMOGRAPHY FINDINGS IN SPINOCEREBELLAR ATAXIA TYPE 3 AND 2
|
Santos, R.S.
|
|
2012
|
18 |
Supplement 2 |
p. S76-S77
2 p.
|
artikel
|
| 48 |
Epidemiology and clinical phenomenology for Parkinson's disease with pain and fatigue
|
Wen, Hong-Bo
|
|
2012
|
18 |
Supplement 2 |
p. S222-S225
4 p.
|
artikel
|
| 49 |
2.206 EPIGALLOCAETECHIN GALLATE (EGCG) INHIBITS A-SYNUCLEIN AGGREGATION: A POTENTIAL AGENT FOR PARKINSON DISEASE
|
Zhang, Y.
|
|
2012
|
18 |
Supplement 2 |
p. S116-
1 p.
|
artikel
|
| 50 |
3.073 EPIGENETIC DNA-METHYLATION IN THE CORE ATAXIN-2 GENE PROMOTER: NOVEL PHYSIOLOGICAL AND PATHOLOGICAL IMPLICATIONS
|
Laffita, J.
|
|
2012
|
18 |
Supplement 2 |
p. S187-
1 p.
|
artikel
|
| 51 |
3.358 ESTABLISHMENT OF 2-DE OF CEREBROSPINAL FLUID AND PRIMARY STUDY OF CSF PROTEOME OF PARKINSON'S DISEASE
|
Li, H.
|
|
2012
|
18 |
Supplement 2 |
p. S233-
1 p.
|
artikel
|
| 52 |
3.126 EVALUATION OF DRUGS ACTING ON CB1-A2A RECEPTOR OLIGOMERS IN RAT MODELS OF PARKINSON'S DISEASE
|
Simola, N.
|
|
2012
|
18 |
Supplement 2 |
p. S195-
1 p.
|
artikel
|
| 53 |
2.268 FIRST 2-YEAR, PLACEBO-CONTROLLED STUDY IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS INDICATES SAFINAMIDE MAY BENEFIT PATIENTS WITH MORE SEVERE DYSKINESIA
|
Anand, R.
|
|
2012
|
18 |
Supplement 2 |
p. S132-S133
2 p.
|
artikel
|
| 54 |
1.263 FUNCTIONAL OUTCOME OF DEFEROXAMINE PRIMED HUMAN ADIPOSE DERIVED MESENCHYMAL STEM CELL TRANSPLANTS IN A RAT MODEL OF HUNTINGTON'S DISEASE
|
Edalatmanesh, M.A.
|
|
2012
|
18 |
Supplement 2 |
p. S62-S63
2 p.
|
artikel
|
| 55 |
Genetic mouse models for understanding LRRK2 biology, pathology and pre-clinical application
|
Yue, Zhenyu
|
|
2012
|
18 |
Supplement 2 |
p. S180-S182
3 p.
|
artikel
|
| 56 |
123I-MIBG myocardial scintigraphy for differentiating Parkinson’s disease from other neurodegenerative parkinsonism: A systematic review and meta-analysis
|
Orimo, Satoshi
|
|
2012
|
18 |
Supplement 2 |
p. 494-500
7 p.
|
artikel
|
| 57 |
2.251 IMPACT OF LEVODOPA ON IMPROVING LIMB SYMMETRY DURING WALKING IN PARKINSON DISEASE
|
Jog, M.S.
|
|
2012
|
18 |
Supplement 2 |
p. S127-S128
2 p.
|
artikel
|
| 58 |
Impulse control disorders in Parkinson's disease
|
Vilas, Dolores
|
|
2012
|
18 |
Supplement 2 |
p. S80-S84
5 p.
|
artikel
|
| 59 |
1.101 INFLUENCE OF PATIENTS' EXPECTATIONS ON NON-MOTOR SYMPTOMS AND QUALITY OF LIFE IN PARKINSON'S DISEASE: A MIXED-METHOD STUDY
|
Lenihan, N.
|
|
2012
|
18 |
Supplement 2 |
p. S35-
1 p.
|
artikel
|
| 60 |
3.242 INHIBITION OF MONOAMINE OXIDASE-B BY CURCUMIN AND TETRAHYDROCURCUMIN IN THE MICE MODEL OF PARKINSON'S DISEASE
|
Muthukumaran, S. Sabesan
|
|
2012
|
18 |
Supplement 2 |
p. S214-
1 p.
|
artikel
|
| 61 |
3.034 INTRACELLULAR TRAFFICKING OF A53T MUTANT ALPHA-SYNUCLEIN INVOLVED IN MICROGLIAL PERSISTENT ACTIVATION
|
Wu, Y.-W.
|
|
2012
|
18 |
Supplement 2 |
p. S177-
1 p.
|
artikel
|
| 62 |
1.130 INVERSE RELATIONSHIP BETWEEN THE CONTENTS OF NEUROMELANIN PIGMENT AND THE VESICULAR MONOAMINE TRANSPORTER-2 AMONG SUBSTANTIA NIGRA AND VENTERAL TEGMENTAL AREA
|
Pasbakhsh, P.
|
|
2012
|
18 |
Supplement 2 |
p. S42-S43
2 p.
|
artikel
|
| 63 |
1.308 INVESTIGATION OF THE NEUROFUNCTIONAL SUBSTRATES BEHIND PRESERVED BICYCLING ABILITIES IN PARKINSON'S DISEASE PATIENTS WITH SEVERE GAIT DISTURBANCES
|
Maliia, M.
|
|
2012
|
18 |
Supplement 2 |
p. S74-
1 p.
|
artikel
|
| 64 |
3.328 IN VITRO AND IN VIVO EVALUATION OF COQ10 LOADED POLYMERIC NANOPARTICLES: AN ATTEMPT TO RESCUE THE CELLS FROM OXIDATIVE STRESS
|
Swarnakar, N.K.
|
|
2012
|
18 |
Supplement 2 |
p. S226-
1 p.
|
artikel
|
| 65 |
3.049 LEVODOPA-INDUCED DYSKINESIA IN PARKINSON'S DISEASE PATIENTS CARRYING THE LEUCINE-RICH REPEAT KINASE 2 (LRRK2) G2019S MUTATION
|
Yahalom, G.
|
|
2012
|
18 |
Supplement 2 |
p. S181-
1 p.
|
artikel
|
| 66 |
LINGO-2 polymorphism and the risk of Parkinson’s disease in Taiwan
|
Su, Feng-Chieh
|
|
2012
|
18 |
Supplement 2 |
p. 609-611
3 p.
|
artikel
|
| 67 |
2.039 LONGITUDINAL PET STUDIES OF MICROGLIAL ACTIVATION IN HUNTINGTON'S DISEASE
|
Tai, Y.F.
|
|
2012
|
18 |
Supplement 2 |
p. S101-
1 p.
|
artikel
|
| 68 |
2.265 LONG-TERM SAFETY AND SUSTAINED EFFICACY OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE
|
Poewe, W.
|
|
2012
|
18 |
Supplement 2 |
p. S131-S132
2 p.
|
artikel
|
| 69 |
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson’s disease: A prospective, open-label extension study
|
Elmer, Lawrence W.
|
|
2012
|
18 |
Supplement 2 |
p. 488-493
6 p.
|
artikel
|
| 70 |
3.031 LOSS OF PINK1 FUNCTION PROMOTES AUTOPHAGY VIA PP2A DOWNREGULATION IN DOPAMINERGIC CELLS AND A MURINE MODEL
|
Yang, W.
|
|
2012
|
18 |
Supplement 2 |
p. S176-S177
2 p.
|
artikel
|
| 71 |
1.291 LOW FREQUENCY RTMS OVER THE PREMOTOR CORTEX SUPPRESS DYSTONIA AND ABNORMAL CORTICAL EXCITABILITY: A CASE REPORT
|
Kim, Y.-H.
|
|
2012
|
18 |
Supplement 2 |
p. S69-S70
2 p.
|
artikel
|
| 72 |
LRRK2 I2020T mutation is associated with tau pathology
|
Ujiie, Sachiko
|
|
2012
|
18 |
Supplement 2 |
p. 819-823
5 p.
|
artikel
|
| 73 |
3.325 MEASURES DEALING WITH EMERGENCIES FOR PATIENTS WITH INTRACTABLE NEUROLOGICAL DISEASE IN SAGAMIHARA AREA
|
Saruwatari, M.
|
|
2012
|
18 |
Supplement 2 |
p. S225-
1 p.
|
artikel
|
| 74 |
1.077 MEMORY MONITORING AND EPISODIC MEMORY OF PARKINSON'S PATIENTS
|
Lv, X.
|
|
2012
|
18 |
Supplement 2 |
p. S29-
1 p.
|
artikel
|
| 75 |
1.5.3 METABOLIC NETWORKING IN CHINESE PATIENTS WITH PARKINSON'S DISEASE IN VARIOUS HOEHN & YAHR STAGES
|
Wang, J.
|
|
2012
|
18 |
Supplement 2 |
p. S3-
1 p.
|
artikel
|
| 76 |
Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
|
Wahlqvist, Mark L.
|
|
2012
|
18 |
Supplement 2 |
p. 753-758
6 p.
|
artikel
|
| 77 |
3.349 MIXED LINEAGE KINASE 2 AND HIPPOCALCIN ARE LOCALIZED IN LEWY BODIES OF PARKINSON'S DISEASE
|
Nagao, M.
|
|
2012
|
18 |
Supplement 2 |
p. S231-
1 p.
|
artikel
|
| 78 |
Molecular pathways in sporadic PD
|
Valente, Enza Maria
|
|
2012
|
18 |
Supplement 2 |
p. S71-S73
3 p.
|
artikel
|
| 79 |
Mouse models for LRRK2 Parkinson's disease
|
Xu, Qing
|
|
2012
|
18 |
Supplement 2 |
p. S186-S189
4 p.
|
artikel
|
| 80 |
2.008 MR IMAGING BIOMARKERS FOR DIFFERENTIATION OF PARKINSON DISEASE FROM HEALTHY CONTROLS USING DIFFUSION TENSOR IMAGING ON 3 TESLA MRI
|
Kumari, R.
|
|
2012
|
18 |
Supplement 2 |
p. S92-S93
2 p.
|
artikel
|
| 81 |
3.18.4 MULTIPLE SYSTEM ATROPHY - ADVANCES IN IMAGING
|
Chen, H.
|
|
2012
|
18 |
Supplement 2 |
p. S169-
1 p.
|
artikel
|
| 82 |
3.3.3 MYOCLONUS: CLINICAL PRESENTATION
|
Roze, E.
|
|
2012
|
18 |
Supplement 2 |
p. S163-
1 p.
|
artikel
|
| 83 |
Neurodegeneration and Inflammation in Parkinson's disease
|
Phani, Sudarshan
|
|
2012
|
18 |
Supplement 2 |
p. S207-S209
3 p.
|
artikel
|
| 84 |
1.12.4 NEUROIMAGING IN PARKINSON'S DISEASE
|
Stoessl, A.J.
|
|
2012
|
18 |
Supplement 2 |
p. S6-
1 p.
|
artikel
|
| 85 |
1.222 NEUROLEPTIC MALIGNANT SYNDROME WITH ATYPICAL NEUROLEPTICS AND DOPAMINE MODULATING DRUGS: SEVEN CASE REPORTS
|
Sharms, J.B.
|
|
2012
|
18 |
Supplement 2 |
p. S52-
1 p.
|
artikel
|
| 86 |
2.310 NEUROPSYCHOLOGICAL FINDINGS IN PATIENTS WITH PARKINSON'S DISEASE SUBMITTED TO UNILATERAL ABLATIVE PROCEDURES
|
Heluani, A.
|
|
2012
|
18 |
Supplement 2 |
p. S143-S144
2 p.
|
artikel
|
| 87 |
1.219 NEUROSYPHILIS PRESENTING WITH PARKINSONISM
|
Fan, L.
|
|
2012
|
18 |
Supplement 2 |
p. S51-
1 p.
|
artikel
|
| 88 |
New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism
|
Barbano, Richard L.
|
|
2012
|
18 |
Supplement 2 |
p. 737-741
5 p.
|
artikel
|
| 89 |
1.057 NOCTURNAL DISTURBANCES IN PARKINSON'S DISEASE: A VALIDATION STUDY OF PARKINSON'S DISEASE SLEEP SCALE-2 JAPANESE VERSION
|
Suzuki, K.
|
|
2012
|
18 |
Supplement 2 |
p. S24-
1 p.
|
artikel
|
| 90 |
No evidence of association between the LINGO4 gene and essential tremor in Chinese Han patients
|
Liang, Hui
|
|
2012
|
18 |
Supplement 2 |
p. 303-305
3 p.
|
artikel
|
| 91 |
3.1.1 OVERVIEW OF PRIMARY MONOGENIC DYSTONIA
|
Spatola, M.
|
|
2012
|
18 |
Supplement 2 |
p. S161-
1 p.
|
artikel
|
| 92 |
3.107 PARAQUAT ACTIVATES THE IRE1/ASK1/JNK CASCADE ASSOCIATED WITH APOPTOSIS IN SH-SY5Y CELLS
|
Son, I.
|
|
2012
|
18 |
Supplement 2 |
p. S191-
1 p.
|
artikel
|
| 93 |
3.311 PARKINSON DISEASE AND PAIN: DOPAMINERGIC MODULATION ON THE MECHANICAL HYPERALGESIA IN HEMIPARKINSONIAN RATS
|
Maciel, S.T.
|
|
2012
|
18 |
Supplement 2 |
p. S222-
1 p.
|
artikel
|
| 94 |
Parkinsonism and dropped head: Dystonia, myopathy or both?
|
Savica, Rodolfo
|
|
2012
|
18 |
Supplement 2 |
p. 30-34
5 p.
|
artikel
|
| 95 |
Parkinson's disease: Molecular risk factors
|
Grünblatt, Edna
|
|
2012
|
18 |
Supplement 2 |
p. S45-S48
4 p.
|
artikel
|
| 96 |
PARK2 variability in Polish Parkinson’s disease patients - interaction with mitochondrial haplogroups
|
Gaweda-Walerych, Katarzyna
|
|
2012
|
18 |
Supplement 2 |
p. 520-524
5 p.
|
artikel
|
| 97 |
1.19.2 PD IN EVOLUTION: PRODROME TO DEGENERATION
|
Schapira, A.
|
|
2012
|
18 |
Supplement 2 |
p. S9-
1 p.
|
artikel
|
| 98 |
Personality profile in essential tremor: A case–control study
|
Thenganatt, Mary Ann
|
|
2012
|
18 |
Supplement 2 |
p. 1042-1044
3 p.
|
artikel
|
| 99 |
2.356 POSSIBILITIES AND LIMITS OF REHABILITATION PROGRAM IN PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES
|
Nica, A.S.
|
|
2012
|
18 |
Supplement 2 |
p. S155-
1 p.
|
artikel
|
| 100 |
2.203 PRECLINICAL EVALUATION OF KOM-1962, A POTENT SELECTIVE INHIBITOR OF CATECHOL-O-METHYLTRANSFERASE, AS A NOVEL DRUG CANDIDATE FOR PARKINSON'S DISEASE
|
Wanajo, I.
|
|
2012
|
18 |
Supplement 2 |
p. S115-
1 p.
|
artikel
|
| 101 |
Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience
|
Ross, G. Webster
|
|
2012
|
18 |
Supplement 2 |
p. S199-S202
4 p.
|
artikel
|
| 102 |
Prevalence of oropharyngeal dysphagia in Parkinson’s disease: A meta-analysis
|
Kalf, J.G.
|
|
2012
|
18 |
Supplement 2 |
p. 311-315
5 p.
|
artikel
|
| 103 |
1.246 PROFUSE SIALORRHEA AND HEMIBALLISM IN A CASE OF ANTI N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ENCEPHALITIS
|
Montero, R. Salazar
|
|
2012
|
18 |
Supplement 2 |
p. S58-
1 p.
|
artikel
|
| 104 |
1.260 PROTECTIVE EFFECT OF ROFECOXIB AND NIMESULIDE AGAINST INTRA-STRIATAL QUINOLINIC ACID INDUCED BEHAVIORAL, OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTIONS IN RATS
|
Kalonia, H.
|
|
2012
|
18 |
Supplement 2 |
p. S62-
1 p.
|
artikel
|
| 105 |
2.15.2 PSYCHOGENIC MOVEMENT DISORDERS (2)
|
Kompoliti, K.
|
|
2012
|
18 |
Supplement 2 |
p. S88-S89
2 p.
|
artikel
|
| 106 |
2.15.1 PSYCHOGENIC MOVEMENT DISORDERS (1)
|
Hallett, M.
|
|
2012
|
18 |
Supplement 2 |
p. S88-
1 p.
|
artikel
|
| 107 |
1.087 PSYCHOSIS: ONE OF THE MOST COMMON NON-MOTOR MANIFESTATIONS IN PD
|
Meng, L.
|
|
2012
|
18 |
Supplement 2 |
p. S31-
1 p.
|
artikel
|
| 108 |
Pulsatile or continuous dopaminomimetic strategies in Parkinson's disease
|
Calandrella, Daniela
|
|
2012
|
18 |
Supplement 2 |
p. S120-S122
3 p.
|
artikel
|
| 109 |
2.359 QUALITY OF LIFE SCALE IN PARKINSON'S DISEASE IN RELATION TO AMBULATORY INDEPENDENCY
|
Kwok, C.M.
|
|
2012
|
18 |
Supplement 2 |
p. S155-S156
2 p.
|
artikel
|
| 110 |
Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson’s disease: A meta-analysis
|
Wu, Xi
|
|
2012
|
18 |
Supplement 2 |
p. 722-730
9 p.
|
artikel
|
| 111 |
2.234 RISK FACTORS FOR LEVODOPA-RELATED DYSKINESIAS IN PARKINSON'S DISEASE
|
Zhang, H.
|
|
2012
|
18 |
Supplement 2 |
p. S123-
1 p.
|
artikel
|
| 112 |
1.118 RISKS OF PARKINSON DISEASE IN PATIENTS WITH AUTOIMMUNE DISORDERS: A NATION-WIDE EPIDEMIOLOGICAL STUDY FROM SWEDEN
|
Li, X.
|
|
2012
|
18 |
Supplement 2 |
p. S40-
1 p.
|
artikel
|
| 113 |
Role of genetic polymorphisms of the dopaminergic system in Parkinson’s disease patients with impulse control disorders
|
Vallelunga, Annamaria
|
|
2012
|
18 |
Supplement 2 |
p. 397-399
3 p.
|
artikel
|
| 114 |
Role of Mendelian genes in “sporadic” Parkinson's disease
|
Lesage, Suzanne
|
|
2012
|
18 |
Supplement 2 |
p. S66-S70
5 p.
|
artikel
|
| 115 |
Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease
|
Pontieri, Francesco E.
|
|
2012
|
18 |
Supplement 2 |
p. 871-875
5 p.
|
artikel
|
| 116 |
Serotonergic action on dorsal striatal function
|
Mathur, Brian N.
|
|
2012
|
18 |
Supplement 2 |
p. S129-S131
3 p.
|
artikel
|
| 117 |
SETX gene novel mutations in a non-French Canadian with ataxia-oculomotor apraxia type 2
|
Ghrooda, Sadik
|
|
2012
|
18 |
Supplement 2 |
p. 700-701
2 p.
|
artikel
|
| 118 |
1.060 SLEEP REGULATORY CENTRES DYSFUNCTION IN PARKINSON'S DISEASE PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS. AN IN VIVO PET STUDY
|
Pavese, N.
|
|
2012
|
18 |
Supplement 2 |
p. S24-S25
2 p.
|
artikel
|
| 119 |
SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population
|
Trotta, Luca
|
|
2012
|
18 |
Supplement 2 |
p. 257-262
6 p.
|
artikel
|
| 120 |
3.214 STRUCTURAL SPECIFICITY OF AKT-MEDIATED NEUROPROTECTION BY OXICAM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AGAINST 1-METHYL-4-PHENYL PYRIDINIUM-INDUCED CELL DEATH
|
Tasaki, Y.
|
|
2012
|
18 |
Supplement 2 |
p. S207-
1 p.
|
artikel
|
| 121 |
3.033 THE AGGREGATED WT-α-SYNUCLEIN AND A53T PROMOTE INFLAMMATION THROUGH ACTIVATION OF NADPH OXIDASE COMPLEX IN BV-2 AND PRIMARY MICROGLIA
|
Kang, W.
|
|
2012
|
18 |
Supplement 2 |
p. S177-
1 p.
|
artikel
|
| 122 |
2.324 THE BILATERAL STN-DBS CAN IMPROVE MOTOR AND NON-MOTOR SYMPTOMS IN MODERATE AND ADVANCED PD PATIENTS: A TWO-YEAR FOLLOW-UP STUDY
|
Fu, X.
|
|
2012
|
18 |
Supplement 2 |
p. S147-
1 p.
|
artikel
|
| 123 |
3.13.3 THE CHINA EXPERIENCE
|
Chan, P.
|
|
2012
|
18 |
Supplement 2 |
p. S166-
1 p.
|
artikel
|
| 124 |
3.140 THE CONTRIBUTION OF THE MYD88-DEPENDENT PATHWAY IN ANIMAL MODELS OF PARKINSONISM
|
Drouin-Ouellet, J.
|
|
2012
|
18 |
Supplement 2 |
p. S199-
1 p.
|
artikel
|
| 125 |
3.360 THE CONTRIBUTION OF THE SELF POLYQ LOAD [SOMATIC MOSAICISM] IN THE CNS TO THE ONSET, DURATION AND PROGRESSION OF SCA2
|
Laffita, J.
|
|
2012
|
18 |
Supplement 2 |
p. S234-
1 p.
|
artikel
|
| 126 |
1.294 THE CURATIVE EFFECT EVALUATIONS FOR BOTULINUM TOXIN-A TREATMENT OF SPASMODIC TORTICOLLIS WITH THE GUIDANCE OF ‘SENSORY TRICK’ COMBINE WITH EMG
|
Ge, H.-M.
|
|
2012
|
18 |
Supplement 2 |
p. S70-
1 p.
|
artikel
|
| 127 |
The effects of gait impairment with and without freezing of gait in Parkinson’s disease
|
Josiah, Anne F.
|
|
2012
|
18 |
Supplement 2 |
p. 239-242
4 p.
|
artikel
|
| 128 |
2.141 THE 18[F]-FDG PET STUDY ON THE IDIOPATHIC PARKINSON'S DISEASE AND SEVERAL PARKINSONIAN-PLUS SYNDROME
|
Zhao, P.
|
|
2012
|
18 |
Supplement 2 |
p. S112-
1 p.
|
artikel
|
| 129 |
2.10.1 THE IRON STORY
|
Riederer, P.F.
|
|
2012
|
18 |
Supplement 2 |
p. S85-
1 p.
|
artikel
|
| 130 |
3.257 THE NEUROPROTECTIVE EFFECTS OF JNK3-N-TAT THROUGH INHIBITING THE ACTIVATION OF JNK3 AND PROTECTING MITOCHODRIA
|
Pan, J.
|
|
2012
|
18 |
Supplement 2 |
p. S217-
1 p.
|
artikel
|
| 131 |
1.074 THE PATTERN OF CORTICAL ATROPHY IN PARKINSON'S DISEASE WITH MILD COGNITIVE IMPAIRMENT ACCORDING TO THE TIMING OF COGNITIVE DYSFUNCTION
|
Lee, P.H.
|
|
2012
|
18 |
Supplement 2 |
p. S28-
1 p.
|
artikel
|
| 132 |
1.236 THE SPECTRUM OF MYOCLONUS IN BLACK AFRICAN PATIENTS - A RETROSPECTIVE ANALYSIS
|
Wynand, L.M.
|
|
2012
|
18 |
Supplement 2 |
p. S55-
1 p.
|
artikel
|
| 133 |
1.132 TYROSINE HYDROXYLASE INTERACTING WITH PHOSPHOLIPID MEMBRANES: A MOLECULAR DYNAMICS STUDY
|
Skjevik, Å.A.
|
|
2012
|
18 |
Supplement 2 |
p. S43-
1 p.
|
artikel
|
| 134 |
3.048 UNDERSTANDING MOLECULAR MECHANISMS UNDERLYING LEUCINE-RICH REPEAT KINASE 2 (LRRK2)-RELATED PARKINSON'S DISEASE (PD)
|
Liu, H.
|
|
2012
|
18 |
Supplement 2 |
p. S180-S181
2 p.
|
artikel
|
| 135 |
3.075 UNEXPANDED AND INTERMEDIATE POLYMORPHISMS AT SCA2 LOCUS (ATXN2) IN THE CUBAN POPULATION: EVIDENCES ABOUT THE ORIGIN OF EXPANDED ALLELES
|
Laffita, J.
|
|
2012
|
18 |
Supplement 2 |
p. S188-
1 p.
|
artikel
|
| 136 |
Upcoming treatments in Parkinson's disease, including gene therapy
|
Rodnitzky, Robert L
|
|
2012
|
18 |
Supplement 2 |
p. S37-S40
4 p.
|
artikel
|
| 137 |
3.157 UPREGULATION OF ETK AFTER RAT TRAUMATIC BRAIN INJURY
|
Chen, K.-Y.
|
|
2012
|
18 |
Supplement 2 |
p. S203-
1 p.
|
artikel
|
| 138 |
Vaccination for Parkinson's disease
|
Schneeberger, A.
|
|
2012
|
18 |
Supplement 2 |
p. S11-S13
3 p.
|
artikel
|
| 139 |
What are the issues facing Parkinson's disease patients at ten years of disease and beyond?: Data from the NPF-QII study
|
Hassan, Anhar
|
|
2012
|
18 |
Supplement 2 |
p. S10-S14
5 p.
|
artikel
|
| 140 |
3.12.1 WHAT ARE THE PITFALLS OF CLINICAL TRIALS IN PARKINSON'S DISEASE?
|
Korczyn, A.D.
|
|
2012
|
18 |
Supplement 2 |
p. S166-
1 p.
|
artikel
|
| 141 |
2.8.1 WHAT REALLY MATTERS IN EARLY AND ADVANCED PARKINSON'S DISEASE
|
Wolters, E.C.
|
|
2012
|
18 |
Supplement 2 |
p. S85-
1 p.
|
artikel
|
| 142 |
1.277 WILSON'S DISEASE IN THE SOUTH OF BRAZIL: A 40 YEARS FOLLOW-UP STUDY
|
Teive, H.A.G.
|
|
2012
|
18 |
Supplement 2 |
p. S66-
1 p.
|
artikel
|
Tijdschrift beschrijving